PCRX - Pacira BioSciences' (PCRX) CEO Dave Stack on Q1 2022 Results - Earnings Call Transcript
Pacira BioSciences, Inc. (PCRX) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Susan Mesco – Head-Investor Relations Dave Stack – Chairman and Chief Executive Officer Charlie Reinhart – Chief Financial Officer Conference Call Participants David Amsellem – Piper Sandler Gregory Renza – RBC Capital Markets Greg Fraser – Truist Securities Anita Dushyanth – Berenberg Capital Serge Belanger – Needham & Company Evan Hua – BMO Capital Presentation Operator Thank you for standing by, and welcome to the Q1 2022 Pacira BioSciences Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentations, there'll be a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded. I would like to turn the conference over to your host, Ms. Susan Mesco, Head of Investor Relations. Please go ahead. Susan Mesco Thank you, Valerie, and good morning, everyone. Welcome to
For further details see:
Pacira BioSciences' (PCRX) CEO Dave Stack on Q1 2022 Results - Earnings Call Transcript